Clinical Research in Latin America


  • 10 times more patients per open trial than in Northern countries
  • High quality sites
  • The highest retention rate
  • Strong regulatory environment
  • 400+ million people
  • Ethnic diversity
  • Prevalence of diseases similar to Northern countries, with similar Standard of Care
  • treatment-naive patients in all therapeutic areas
  • Population concentrated in major urban areas
  • One language for all countries, except for Brazil
  • Similar time Zone as the USA/Europe (0 – 5 hours difference)
  • High standard communications and IT
  • Climate from Rainforest to Antarctic ice
  • Quality proven regional vendors for supporting services: couriers, warehouses, central labs, meeting locations
  • Reverse seasonality complementary to Northern hemisphere
  • Highly qualified sites and experienced Investigators eager to participate in clinical trials
  • Tradition of high quality medical care
  • Qualified medical personnel, trained and experienced in ICH/GCP
  • Strong Regulatory environment, with well established regulations
  • Approval timelines similar to Eastern Europe when local knowledge is applied
  • Recruitment rates are much higher than in USA and Europe
  • Strong patient-doctor relationship leading to good compliance and the highest retention rates

Country
(data)
Est. Population
(in millions)
Open Trials
Sep 2014
NIT
Sep 2014
Largest City
(pop in millions)
Open Trials
(/100.000 inhabitants)
FDA
1980-2010 (#OAI)
Brazil 193 1092 122 Sao Paulo(20) 0.56 29 (0)
Mexico 108 405 67 Mexico DF(29) 0.375 25 (5)
Argentina 44 302 60 Buenos Aires(13) 0.69 40 (1)
Chile 17 178 26 Santiago(7) 1.05 9 (0)
Peru 29 125 8 Lima(8) 0.43 8 (2)
Colombia 45 186 24 Bogota(7.8) 0.41 3 (0)

Source: clinicaltrials.gov